Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patients
about
Correlation between IL36α and IL17 and Activity of the Disease in Selected Autoimmune Blistering DiseasesExpression levels and genetic polymorphisms of interleukin-2 and interleukin-10 as biomarkers of Graves' diseaseAssociation of Angiotensin-Converting Enzyme (ACE) Gene Polymorphism with Inflammation and Cellular Cytotoxicity in Vitiligo PatientsAssociation of IFN-γ : IL-10 Cytokine Ratio with Nonsegmental Vitiligo PathogenesisTumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo.Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo.The Evaluation of Endothelin-1 and Endothelin Receptor Type A Gene Polymorphisms in Patients with VitiligoA quantitative increase in regulatory T cells controls development of vitiligo.The role of tumor necrosis factor-α in the pathogenesis of vitiligo.Genetic variants of interferon-gamma and its mRNA expression and inflammatory parameters in the pathogenesis of vitiligo.Cytokine Indexes in Pemphigus Vulgaris: Perception of Its Immunpathogenesis and Hopes for Non-Steroidal Treatment.No Association between Vitiligo and Obesity: A Case-Control Study.CXCL-10 and Interleukin-6 are reliable serum markers for vitiligo activity: A multicenter cross-sectional study.Decreased regulatory T-cells and CD4(+) /CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo.Serum Levels of Interleukin-2 in Patients with Alopecia Areata: Relationship with Clinical Type and Duration of the Disease
P2860
Q33762424-E3D4153D-5669-444E-882C-0A6AAAC09261Q35048708-53858B4F-9CD1-4E89-9358-9D63DA883C2EQ35692379-35570A92-2723-45F2-8CAE-E1FAE7EF459CQ36084225-D15CFD76-4EFA-4F2A-9FF2-0287A0654D20Q36094915-1B8CB128-2511-4E97-87FF-D913A206452DQ36389114-F04CF5C9-9DDE-4CFB-929D-6F36DBEB4887Q36607064-B0CE0045-E34D-4E44-97E0-96DBB3BE739DQ37707149-B6B09728-002B-4CBA-94CC-68D8A2086FB8Q38126326-F69B4B3D-80BD-4B29-96E7-DE14B992840DQ46490608-EC24CAF7-580C-4B9A-AE6D-0CD45415F1A5Q47098800-DACCD35C-BB70-4711-9360-71903824586CQ47688518-7A77D336-AE68-41FB-B34F-5A0FCC0E3F5AQ48377795-9258064B-7FC7-4BD7-971B-D6F610BE9F97Q51075988-691133B1-BFB6-4031-B55E-D80577F8AF6EQ58602705-D1152EF8-E6D8-4D82-9CFD-CAE532D9CD69
P2860
Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patients
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patients
@ast
Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patients
@en
type
label
Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patients
@ast
Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patients
@en
prefLabel
Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patients
@ast
Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patients
@en
P2093
P2860
P356
P1476
Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patients
@en
P2093
S S Pandey
Suman Singh
Usha Singh
P2860
P356
10.4103/0019-5154.92668
P407
P577
2012-01-01T00:00:00Z